Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.92
- Piotroski Score 2.00
- Grade Market Outperform
- Symbol (HOOK)
- Company HOOKIPA Pharma Inc.
- Price $2.29
- Changes Percentage (-15.81%)
- Change -$0.43
- Day Low $2.19
- Day High $2.75
- Year High $11.30
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $3.00
- High Stock Price Target $3.00
- Low Stock Price Target $3.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.48
- Trailing P/E Ratio -1.71
- Forward P/E Ratio -1.71
- P/E Growth -1.71
- Net Income $-81,580,000
Income Statement
Quarterly
Annual
Latest News of HOOK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Bengals are 1-6 in one-score games. So who's on the hook for their inability to finish?
Bengals struggle to finish games, with a 1-6 record in close matchups. The team faces challenges in execution, coaching decisions, and key player performances, leaving their season in jeopardy. Coach ...
By The New York Times | 1 day ago -
Chicago owed nearly $20 million in police overtime for special events this year; taxpayers may be on the hook
Chicago has spent $22.6 million on police overtime for special events, but only $2 million has been reimbursed by event producers. This discrepancy raises concerns about accountability and enforcement...
By CBS News | 2 days ago -
Most Chicago street festivals aren't paying police overtime, leaving taxpayers on the hook
Chicago has been covering the cost of police overtime at street festivals, despite organizers being required to pay. This has raised concerns about taxpayer costs, officer burnout, and lack of transpa...
By CBS News | 6 days ago
